Quantcast

Latest Thyroid neoplasm Stories

2009-02-06 14:47:00

REYKJAVIK, Iceland, Feb. 6 /PRNewswire-FirstCall/ -- Scientists at deCODE genetics (Nasdaq: DCGN) today present the discovery of two single letter variations in the sequence of the human genome (SNPs) conferring substantial increased risk of thyroid cancer. The two SNPs, located on chromosomes 9q22 and 14q13, are the first common variants replicated in multiple populations ever associated with increased risk of the disease. They were found through the analysis of the genomes of a total of...

2009-01-20 12:35:23

U.S. scientists have found an experimental anaplastic thyroid cancer drug can activate a powerful tumor suppressor that has the ability to halt cell growth. Researchers at the Mayo Clinic campus in Jacksonville, Fla., say few other cancer drugs have that ability and the drug, called RS5444, might be useful in treating other cancers. The researchers found human anaplastic thyroid tumor cells treated with RS5444 expressed a protein known as p21, which inhibited cell replication and tumor...

2009-01-20 11:18:50

Researchers at Mayo Clinic have found that the experimental drug they are testing to treat a deadly form of thyroid cancer turns on a powerful tumor suppressor capable of halting cell growth. Few other cancer drugs have this property, they say. In the Feb. 15 issue of Cancer Research (available online Jan. 20), they report that RS5444, being tested in a Phase 1/2 clinical trial to treat anaplastic thyroid cancer, might be useful for treating other cancers. The agent is also known as CS-7017....

2009-01-02 13:22:07

Physicians now able to accurately distinguish cancerous lymph nodes from healthy tissue in cancer patients, according to article in the Journal of Nuclear Medicine In a study to determine the diagnostic value of molecular imaging in nodal staging of patients with thyroid cancer, researchers were able for the first time to accurately distinguish between cancerous cells in regional lymph nodes and normal residual thyroid tissue directly after surgery. Researchers from the University of...

2008-10-21 03:00:08

WALTHAM, Mass., Oct. 21, 2008 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that data from clinical trials with its vascular disrupting agent (VDA) product candidate, ZYBRESTAT (fosbretabulin) (formerly referred to as combretastatin A4 phosphate / CA4P), will be presented at the upcoming 12th Biennial Meeting of the International Gynecologic Cancer...

2008-09-15 18:00:37

MUM-OF-TWO Cath Mullinder was given financial support after cancer stopped her from working. Cath, who is an assistant social worker for Macmillan Cancer Support, was earlier this year diagnosed with thyroid cancer. Cath, of Wylam, was given radioactive iodine treatment at Newcastle General Hospital. The 44-year-old was in isolation for 48 hours and put on thyroxin medication. Living costs became a concern, as Cath was unable to work because of the cancer. With twin daughters Rachel and...

2008-09-07 15:00:25

Participants of a Rehabilitation Institute of Chicago gala say movie reviewer Roger Ebert is an inspiration for surviving multiple bouts with cancer. Medicine Ball gala guest Ellen Tully said the noted movie critic should be the target for emulation for his ability to survive his ongoing medical fight with both salivary gland and thyroid cancer, the Chicago Sun-Times reported Sunday. "He's somebody for everyone in Chicago to emulate because he keeps going and going," Tully said at...

2008-08-30 09:00:24

By Montone, Kathleen T Baloch, Zubair W; LiVolsi, Virginia A Context.-Hurthle cells are eosinophilic, follicular-derived cells that are associated with a variety of nonneoplastic and neoplastic thyroid lesions. The differential diagnosis of Hurthle cell lesions is quite broad. Objective.-To review the pathologic conditions associated with Hurthle cells in the thyroid and to discuss pathology of thyroid lesions associated with oncocytic cytology. Data Sources.-A variety of thyroid...

2008-07-28 06:00:25

Exelixis, Inc. (Nasdaq:EXEL) today announced that it has notified GlaxoSmithKline (GSK) that it has achieved proof-of-concept for XL184 under the collaboration agreement between GSK and Exelixis, and has submitted the corresponding data report to GSK. Under the agreement, GSK has 90 days to review the data and decide whether to exercise its option to select the compound for further development and commercialization. If GSK selects XL184, Exelixis would receive a $55 million milestone...

2008-07-27 12:00:20

By Megan Williams, The Free Lance-Star, Fredericksburg, Va. Jul. 27--When Anita Kaissi found herself feeling constantly sluggish, she thought it was because she had just had a baby. It took doctors three months to determine that her fatigue, hair loss and dry skin weren't postpartum depression, but postpartum thyroiditis, an inflammation of the thyroid that makes it overactive. "They told me it was all in my head," Kaissi said. As it turns out, it was all in her neck. The thyroid,...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.